Description
Gaviscon Dual Act Liquid offers effective relief from common symptoms of gastro-oesophageal reflux such as heartburn, acid regurgitation, and indigestion. This oral suspension is particularly beneficial for use after meals and is suitable during pregnancy, providing a versatile solution for those experiencing reflux oesophagitis or hiatus hernia.
Key Benefits
- Fast Relief: Acts rapidly, typically within 3 to 4 minutes, providing soothing comfort.
- Long-lasting Effect: Delivers relief for up to 4 hours, allowing for more comfortable daily activities.
Unique Mechanism
Gaviscon Dual Act Liquid works through a dual mechanism:
- Neutralization: The antacid properties help neutralize excess stomach acid, alleviating pain and discomfort.
- Protective Barrier: Forms an alginate 'raft' that sits on top of stomach contents, preventing acid from refluxing into the oesophagus.
Active Ingredients
Each 10 mL dose contains:
- Sodium Alginate
- Sodium Bicarbonate
- Calcium Carbonate
These ingredients collaborate to provide the dual action effect, ensuring both immediate and sustained relief.
Additional Features
- Flavour Options: Available in peppermint, mixed berry, banana, or fennel.
- No Sugar or Colour Additives: Making it a suitable option for a wide range of dietary needs.
Usage Instructions
- Adults and Children Over 12: Take 10–20 mL after meals and at bedtime.
- Children 6–12: Take 5–10 mL, with use recommended only on medical advice for those under 12.
Shake well before use and ensure the cap seal is intact before first opening.
Precautions
- Contains sodium and calcium; individuals on restricted diets or with certain health conditions should consult a healthcare professional.
- Not recommended for children under 6 years.
- Store below 25°C and do not refrigerate.
Packaging
Available in various bottle sizes and convenient sachets, Gaviscon Dual Act Liquid is designed for easy administration and portability.
Regulatory Information
This product is registered with relevant health authorities in Australia and New Zealand, ensuring compliance with safety and quality standards. It is not classified as hazardous and poses no significant health risks when used as directed.
Gaviscon Dual Act Liquid remains a trusted choice for managing reflux symptoms, offering peace of mind through its well-established formulation and comprehensive relief strategy.
